mikofenolátmofetil

Mycophenolate mofetil is an immunosuppressant medication used to prevent organ rejection after a transplant and to treat certain autoimmune diseases. It is a prodrug, meaning it is converted into its active form, mycophenolic acid, in the body. Mycophenolic acid works by inhibiting the production of certain white blood cells called lymphocytes, which are crucial components of the immune system that can attack transplanted organs or healthy tissues in autoimmune conditions.

Mycophenolate mofetil is commonly prescribed after kidney, liver, or heart transplants to reduce the risk of the body rejecting the new organ. It is also used in the management of conditions such as lupus nephritis (kidney inflammation caused by lupus) and rheumatoid arthritis. The medication is typically taken orally in tablet or capsule form, or intravenously.

Like all medications, mycophenolate mofetil can cause side effects. The most common include gastrointestinal issues such as nausea, vomiting, diarrhea, and abdominal pain. It can also suppress the immune system, making individuals more susceptible to infections. Other potential side effects may include headache, anemia, and tremors. Due to its immunosuppressive effects, regular monitoring by a healthcare professional is essential. Mycophenolate mofetil is a prescription-only medication and should only be used under the guidance of a qualified physician.